Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies

Clinical Neurology

Volumn 48, Issue 1, 2008, Pages 11-24

  Orimo, Satoshi ^a  

^a Mutual Aid Association of Public School Teachers

Author keywords

Cardiac sympathetic denervation; Dementia with Lewy bodies; meta iodobenzylguanidine (MIBG); Parkinson's disease; synuclein

Indexed keywords

3 IODOBENZYLGUANIDINE IODINE 123; ALPHA SYNUCLEIN; CONTRAST MEDIUM; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; HEART DENERVATION; HEART SCINTISCANNING; HUMAN; HUMAN TISSUE; LEWY BODY; MOTOR DYSFUNCTION; NERVE FIBER; PARKINSON DISEASE; PATHOLOGY; SYMPATHETIC NERVE;

EID: 38749098753     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.48.11     Document Type: Article

References (76)

1. Rajput AH, Rozdilsky B, Rajput A: Accuracy of the clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci 1991; 18: 275-278
2. Hughes AJ, Daniel SE, Kilford L, et al: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184
3. Hughes AJ, Daniel SE, Lees AJ: Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001; 57: 1497-1499
4. 131I] iodobenzylguanidine. J Nucl Med 1980; 21: 349-353
5. Japanese source
6. Minardo JD, Tuli MM, Moch BH, et al: Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation 1988; 78: 1008-1019
7. Stanton MS, Tuli MM, Radtke NL, et al: Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123 metaiodobenzylguanidine. J Am Coll Cardiol 1989; 4: 1519-1526
8. Schofer J, Spielmann R, Schuchert A, et al: Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12: 1252-1258
9. Farget D, Wolf J-E, Vanzetto G, et al: Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis. J Nucl Med 1993; 34: 57-60
10. Sisson JC, Shapiro B, Meyers L: Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987; 28: 1625-1636
11. Rabinovitch MA, Rose CP, Schwab AJ, et al: A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 1993; 34: 589-600
12. Merlet P, Valette H, Dubobis-Randé J-L, et at Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33: 471-477
13. Japanese source
14. Japanese source
15. 123I] iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 1994; 49: 81-84
16. Japanese source
17. Japanese source
18. Japanese source
19. Japanese source
20. Japanese source
21. 123I-MIBG scintigraphy in pure progressive autonomic failure. Eur Neurol 1997; 38: 291-296
22. 123I-metaiodobenzyl guanidine in Parkinson's disease. Nucl Med Commun 1998; 19: 137-142
23. Yoshita M: Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 metaiodobenzylguanidine myocardial scintigraphy. J Neurol Sci 1998; 155: 60-67
24. 123I-MIBG uptake in Parkinson's disease. Acta Neurol Scand 1998; 97: 303-306
25. 123I] iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand 1998; 97: 307-314
26. 123 I- metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 189-194
27. 123I-MIBG uptake by the heart in Parkinson's disease: ssessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med 1999; 40: 371-375
28. 123I] MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999; 53: 1020-1025
29. Taki J, Nakajima K, Hwang E-H, et al: Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 2000; 27: 566-573
30. Takatsu H, Nishida H, Satomi K: Differentiation of Parkinson's disease from multiple-system atrophy measuring cardiac iodine-123 metaiodobenzylguanidine accumulation. JAMA 2000; 284: 44-45
31. Takatsu H, Nishida H, Matsuo H, et al: Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000; 41: 71-77
32. Druschky A, Hilz MJ, Platsch G, et al: Differentiation of Parkinson's disease and multiple system atrophy in early disease by means of I-123-MIBG-SPECT. J Neurol Sci 2000; 175: 3-12
33. 123I- metaiodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001; 70: 781-783
34. 123I] MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2001; 71: 583-588
35. Japanese source
36. 123I] MIBG myocardial scintigraphy differentiates corticobasal degeneration from Parkinson's disease. Intern Med 2003; 42: 127-128
37. 123I-MIBG uptake in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74: 423-426
38. 123I] MIBG myocardial scintigraphy for differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. Intern Med 2003; 42: 917-918
39. Courbon F, Brefel-Courbon C, Thalamas C, et al: Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease, Mov Disord 2003; 18: 890-897
40. Akincioglu C, Unlu M, Tunc T: Cardiac innervation and clinical correlates in idiopathic Parkinson's disease. Nucl Med Commun 2003; 24: 267-271
41. Campos V, Rebollo AC, Jimenez-Hoyuela JM, et al: Early alterations of adrenergic cardiac function in Parkinson's disease. Neurologia 2004; 19: 53-58
42. 123I-MIBG scintigraphy in patients with essential tremor. Mov Disord 2007; 21: 1235-1238
43. 123I-metaiodobenzylguanidine. Diabetes 1992; 41: 1069-1075
44. 123I- metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 1996; 45: 801-805
45. Goldstein DS, Holmes C, Cannon RO III, et al: Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 1997; 336: 696-702
46. Goldstein DS, Holmes C, Li S-T, et al: Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 2000; 133: 338-347
47. Orimo S: Decreased cardiac uptake of MIBG is a potential biomarker for the presence of Lewy bodies. J Neurol 2007; 254 (Suppl 14): 21-28
48. Japanese source
49. Japanese source
50. 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease. Neurology 2007; 69: 1460-1465
51. 123I- metaiodobenzylguanidine uptake in patients with Parkinson's disease. Mov Disord 2005; 20: 1419-1424
52. Nakamura T, Hirayama M, Ito H, et al. Dobutamine stress test unmasks cardiac sympathetic denervation in Parkinson's disease. J Neurol Sci 2007; 15: 133-138
53. Japanese source
54. Orimo S: MIBG myocardial scintigraphy in the early diagnosis of Parkinson's disease. CNS Drugs 2007; 21 (Special Issue): 11-15
55. Li S-T, Dendi R, Goldstein DS: Progressive loss of cardiac sympathetic innervation in Parkinson's disease. Ann Neurol 2002; 52: 220-223
56. 123I- metaiodobenzyl-guanidine uptake in autosomal recessive juvenile parkinsonism: first case report Mov Disord 2005; 20: 634-636
57. Orimo S, Amino T, Yokochi M, et al: Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Mov Disord 2005; 20: 1350-1355
58. Singleton A, Gwinn-Hardy K, Sharabi Y, et al: Association between cardiac denervation and parkinsonism caused by α-synuclein gene triplication. Brain 2004; 127: 768-772
59. Nishioka K, Hayashi S, Farrer MJ, et al: Clinical heterogeneity of α-synuclein gene duplication in Parkinson's disease. Ann Neurol 2006; 59: 298-309
60. Tomiyama H, Li Y, Funayama M, et al: Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries. Mov Disord 2006; 21: 1102-1108
61. Goldstein DS, Imrich R, Peckham E, et at Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutations. Neurology 2007; 69: 1-6
62. Dampney RA: Functional organization of central pathways regulating the cardiovascular system. Physio Rev 1994; 74: 323-364
63. Owman C: Autonomic innervation of the cardiovascular system. In Handbook of chemical neuroanatomy, ed by Bjorklund A, Hokfelt T, Owman C, et al, Elsevier, Amsterdam, 1988, pp 327-389
64. Kawano H, Okada R, Yano K: Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels 2003; 18: 32-39
65. Orimo S, Ozawa E, Oka T, et al: Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. Neurology 2001; 57: 1140-1141
66. Amino T, Orimo S, Ihoh Y, et al: Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol 2005; 15: 29-34
67. Neuropathology 2006 : 26 Suppl : 63
68. Clin Neurosci 2006 ; 24 : 502-503
69. 123I- metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease. J Neurol Sic 2006; 243: 101-104
70. Orimo S, Amino T, Itoh Y, et al: Cardiac Sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropatol 2005; 109: 583-588
71. Orimo S, Oka T, Miura H, et al: Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002; 73: 776-777
72. Braak H, Del Tredici K, Rüb U, et al: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211
73. Orimo S, Takahashi A, Uchihara T, et al: Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 2007; 17: 24-30
74. Orimo S, Kanazawa T, Nakamura A, et al: Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol 2007; 113: 81-86
75. Daniel SE: The neuropathology and neurochemistry of multiple system atrophy. In Autonomic Failure, ed by Mathias CJ, Bannister SR, Oxford University Press, Oxford, 1999, pp 321-328
76. Orimo S, Uchihara T, Nakamura A, et al: Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain (in press)